Development of a Set of Nomograms to Predict Acute Lower Gastrointestinal Toxicity for Prostate Cancer 3D-CRT

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 4, 2008, Pages 1065-1073

  Valdagni, Riccardo ^a   Rancati, Tiziana ^a   Fiorino, Claudio ^b   Fellin, Gianni ^c   Magli, Alessandro ^d   Baccolini, Michela ^e   Bianchi, Carla ^d   Cagna, Emanuela ^f   Greco, Carlo ^g   Mauro, Flora A ^e   Monti, Angelo F ^f   Munoz, Fernando ^h   Stasi, Michele ^h,i   Franzone, Paola ^j   Vavassori, Vittorio ^d  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SANTA CHIARA HOSPITAL   (Italy)

^d OSPEDALE DI CIRCOLO   (Italy)

^e MARIA CECILIA HOSPITAL   (Italy)

^f SANT ANNA HOSPITAL   (Italy)

^g UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^h CANDIOLO CANCER INSTITUTE   (Italy)

ⁱ MAURIZIANO HOSPITAL   (Italy)

^j C Arrigo Children's Hospital   (Italy)

more..

Author keywords

Acute LGI toxicity; Conformal radiotherapy; Nomograms; Prostate radiotherapy

Indexed keywords

COMPUTER NETWORKS; ELECTROTHERAPEUTICS; FORECASTING; HEALTH; IRRADIATION; NOMOGRAMS; ONCOLOGY; OPERATING ROOMS; PIGMENTS; RADIATION; RADIOTHERAPY; RISK ASSESSMENT; THREE DIMENSIONAL; TISSUE; TOXICITY; TUMORS; VARIATIONAL TECHNIQUES;

ANDROGEN DEPRIVATION (AD); ELSEVIER (CO); EUROPEAN; FECAL INCONTINENCE; GASTROINTESTINAL (GI); GASTROINTESTINAL (GI) TOXICITIES; NORMAL TISSUES; ODDS RATIOS; PROSTATE CANCER (CAP); RADIATION ONCOLOGY; RECTAL TOXICITY; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY (3D CRT); TOXICITY PREDICTIONS;

RESEARCH AND DEVELOPMENT MANAGEMENT;

ANDROGEN; ANTICOAGULANT AGENT;

ARTICLE; BLEEDING; COMPUTER ASSISTED RADIOTHERAPY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; DOSIMETRY; FECES ANALYSIS; FECES INCONTINENCE; GASTROINTESTINAL TOXICITY; HEMORRHOID; HISTOGRAM; HUMAN; INTESTINE; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; ONCOLOGY; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RECTUM; RISK; SCORING SYSTEM; SELF EVALUATION; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE;

ALGORITHMS; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, RADIATION; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; ITALY; MALE; MODELS, BIOLOGICAL; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 45449088683     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.11.037     Document Type: Article

References (35)

1. Woo S., Kaplan I., Roach M., et al. Formula to estimate risk of pelvic lymph node metastasis from the total Gleason score for prostate cancer [Letter]. J Urol 140 (1988) 387
2. Lehrer S., and Song H.K. Nomogram for predicting the risk of node involvement in prostate cancer, give pretreatment prostate-specific antigen and Gleason score. Int J Radiat Oncol Biol Phys 30 (1994) 509-510
3. Roach III M., Marquez C., Yuo H.S., et al. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 28 (1994) 33-37
4. Ohori M., Kattan M.W., Koh H., et al. Predicting the presence and side of extracapsular extension: A nomogram for staging prostate cancer. J Urol 171 (2004) 1844-1849
5. Koh H., Kattan M.W., Scardino P.T., et al. A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol 170 (2003) 1203-1208
6. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 17 (1999) 168-172
7. Kattan M.W., Zelefsky M.J., Kupelian P.A., et al. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 18 (2000) 3352-3359
8. Parker C.C., Norman A.R., Huddart R.A., et al. Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer. Br J Cancer 86 (2002) 686-691
9. Kattan M.W., Zelefsky M.J., Kupelian P.A., et al. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol 21 (2003) 4568-4571
10. Kupelian P.A., Buchsbaum J.C., Patel C., et al. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Int J Radiat Oncol Biol Phys 52 (2002) 704-711
11. D'Amico A.V., Moul J.W., Carroll P.R., et al. Surrogate endpoint for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst 95 (2003) 1376-1383
12. Zhou P., Chen M.H., McLeod D., et al. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol 23 (2005) 6992-6998
13. Gulliford S.L., Webb S., Rowbottom C.G., et al. Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate. Radiother Oncol 71 (2004) 3-12
14. Dash A., Dunn R.L., Resh J., et al. Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: Multivariate nomogram to assist patient counseling. Urology 64 (2004) 117-122
15. Tewari A., Gamito E.J., Crawford E.D., and Menon M. Biochemical recurrence and survival prediction models for the management of clinically localized prostate cancer. Clin Prostate Cancer 2 (2004) 220-227
16. Peeters S.T., Lebesque J.V., Heemsbergen W.D., et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1151-1161
17. Boersma L.J., van den B.M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
18. Cozzarini C., Fiorino C., Ceresoli G.L., et al. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy). Int J Radiat Oncol Biol Phys 55 (2003) 688-694
19. Fiorino C., Sanguineti G., Cozzarini C., et al. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 953-962
20. Greco C., Mazzetta C., Cattani F., et al. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. Radiother Oncol 69 (2003) 215-222
21. Jackson A. Partial irradiation of the rectum. Semin Radiat Oncol 11 (2001) 215-223
22. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685-698
23. Rancati T., Fiorino C., Gagliardi G., et al. Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS 0101). Radiother Oncol 73 (2004) 21-32
24. Sohn M., Yan D., Liang J., et al. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. Int J Radiat Oncol Biol Phys 67 (2007) 1066-1073
25. Peeters S.T., Heemsbergen W.D., van Putten W.L., et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
26. Peeters S.T., Hoogeman M.S., Heemsbergen W.D., et al. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: Normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys 66 (2006) 11-19
27. Vavassori V., Fiorino C., Rancati T., et al. Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: Results of a prospective multicenter study. Int J Radiat Oncol Biol Phys 67 (2007) 1401-1410
28. Fiorino C., Vavassori V., Sanguineti G., et al. Rectum contouring variability in patients treated for prostate cancer: Impact on rectum dose-volume histograms and normal tissue complication probability. Radiother Oncol 63 (2002) 249-255
29. Foppiano F., Fiorino C., Frezza G., et al. The impact of contouring uncertainty on rectal 3D dose-volume data: Results of a dummy run in a multicenter trial (AIROPROS 0102). Int J Radiat Oncol Biol Phys 57 (2003) 573-579
30. Ross P.L., Scardino P.T., and Kattan M.W. A catalog of prostate cancer nomograms. J Urol 165 (2001) 1562-1568
31. Ross P.L., Gerigk C., Gonen M., et al. Comparisons of nomograms and urologists' predictions in prostate cancer. Semin Urol Oncol 20 (2002) 82-88
32. Potters L. Nomograms for clinically localized prostate cancer. Part II: Radiation therapy. Semin Urol Oncol 20 (2002) 131-139
33. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55 (2000) 241-249
34. Heemsbergen W.D., Peeters S.T., Koper P.C., et al. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: Consequential late damage. Int J Radiat Oncol Biol Phys 66 (2006) 3-10
35. Wang L., Hricak H., Kattan M.W., et al. Prediction of seminal vesicle invasion in prostate cancer: Incremental value of adding endorectal MR imaging to the Kattan nomogram. Radiology 242 (2007) 182-188